RxDoctor Payments DataLook up a doctor →

Rhapsido: payments to doctors

Payments that named Rhapsido as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$936K
Providers
11,716
Transactions
23,969
Average per transaction
$39

The per-transaction average — $39 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,716 providers the average total is $80, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis$895,76495.7%
Novartis Pharma AG$40,0864.3%
← All drugs & devices